Please use this identifier to cite or link to this item:
https://hdl.handle.net/10923/21639
| Type: | Article |
| Title: | Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma |
| Author(s): | MAHONEY, KATHLEEN M.
JACOBUS, SUSANNA
BHATT, RUPAL S.
SONG, JIAXI
CARVO, INGRID
CHENG, SU-CHUN
SIMPSON, MEKAILAH
André Poisl Fay
PUZANOV, IGOR
MICHAELSON, M. DROR
ATKINS, MICHAEL B.
MCDERMOTT, DAVID F.
SIGNORETTI, SABINA
CHOUEIRI, TONI K. |
| In: | Clinical Genitourinary Cancer |
| Issue Date: | 2016 |
| Volume: | 14 |
| Issue: | 4 |
| First page: | 304 |
| Last page: | 313.e6 |
| URI: | https://hdl.handle.net/10923/21639 |
| DOI: | DOI:10.1016/j.clgc.2016.02.007 |
| ISSN: | 1558-7673 |
| Appears in Collections: | Artigo de Periódico
|
All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.
